Trial Profile
Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer a Single Arm Multi-center Open-label Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Icotinib (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- Acronyms CHALLENGE
- Sponsors Betta Pharmaceuticals Co Ltd
- 21 Nov 2017 New trial record